Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) Stock Price, Quote & AI Analysis

Live AMRX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Amneal Pharmaceuticals, Inc. Class A Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

AMRX
Amneal Pharmaceuticals, Inc. Class A Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
13.640000
High
14.295000
Low
13.640000
Volume
2,901,962
VWAP
-
Market Cap
$4,300,484,745.60
52W Range
$6.69 - $15.00
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 27, 2026 Q4
Before Open
EPS Estimate: $0.1842
Revenue Estimate: $824,053,410.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Amneal Pharmaceuticals, Inc. Class A Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Amneal Pharmaceuticals, Inc. Class A Common Stock Overview

Company information

Company Overview

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

Company Details
Market Cap
$4.46B
Shares Outstanding
314,363,000
Weighted Shares Outstanding
314,362,920
CEO
Chintu Patel
Employees
8,100
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Amneal Pharmaceuticals, Inc. Class A Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...